Top Markets
#1 Black Phoenix Black Phoenix +365.30%
#2 Islamic Coin Islamic Coin +158.16%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.04%
#5 Akedo Akedo +36.85%
#6 BasedHype BasedHype +32.76%
#7 Acurast Acurast +28.33%
#8 Cryptopia Cryptopia +21.42%
#9 Quantum Resistant Ledger Quantum Resistant Ledger +20.60%
#10 GoPlus Security GoPlus Security +19.08%
Coin of the day
Black Phoenix Black Phoenix
설정
언어
한국어
통화
USD
테마
Neuropathix, Inc. Neuropathix, Inc.

Neuropathix, Inc.

NPTX
주식 순위 #41304
Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying,... Neuropathix, Inc. is a biopharmaceutical firm dedicated to identifying, advancing, and bringing to market innovative treatments derived from its exclusive platform of synthetic cannabinoid derivatives. The company's efforts are concentrated on the research and preclinical development of chemical compounds like KLS-13019, KLS-13023, and KLS-13022, alongside associated molecules and synthetic cannabidiol-based therapies. These investigational drugs are being explored for their potential application in treating various conditions, including chemotherapy-induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. Previously operating as Kannalife, Inc., the organization rebranded as Neuropathix, Inc. in November 2020. Established in 2010, Neuropathix, Inc. maintains its headquarters in Doylestown, Pennsylvania.
주가
$0.0003
마지막 동기화: 2023-06-13
시가총액
$28.14K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Neuropathix, Inc. (NPTX)

카테고리

Healthcare
Neuropathix, Inc. (NPTX)의 주가 이력
최고 종가: $0.00 (2023-06-01 기준)

최저 종가: $3.83 (2019-12-01 기준)
Neuropathix, Inc.의 주가 이력 (2019 ~ 2026)
연간 주가 성과
연도 성과
2023 -94.99%
2022 -87.62%
2021 -79.16%
2020 -93.93%
2019 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $745.48 9.02%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $260.24 16.81%
BE